Gastrointestinal Capsule Manufacturer in India

WHO-GMP certified gastrointestinal hard gelatin capsule manufacturing — PPIs, antidiarrhoeals, antispasmodics and laxatives — for domestic institutional supply and international export across 15+ countries.

Key Highlights

  • WHO-GMP
    Certified Facility

  • 1,000+
    Approved Formulations

  • Export-Ready
    15+ Countries

  • DCGI Approved
    Formulations

About

Gastrointestinal capsule manufacturing at 9M India

9M India manufactures a comprehensive range of gastrointestinal hard gelatin capsules at its WHO-GMP certified facility in Birkoni, Chhattisgarh. Gastrointestinal disorders represent one of the most common disease burden categories globally, with consistently high demand for proton pump inhibitors, antidiarrhoeals, antispasmodics and laxative formulations across all markets. Our GI capsule portfolio covers PPIs (Omeprazole, Lansoprazole, Pantoprazole), antidiarrhoeals (Loperamide), antispasmodics (Dicyclomine), and combination GI formulations — all manufactured as enteric-coated pellet or standard hard gelatin capsules to BP/USP pharmacopoeial standards with full stability data and export documentation.

Therapeutic sub-categories — Gastrointestinal Drugs

Our gastrointestinal drugs capsule range covers the following sub-categories and key molecules:

Sub-Category Key Molecules
Proton Pump Inhibitors (PPIs) Omeprazole 20mg / 40mg, Lansoprazole 15mg / 30mg, Pantoprazole 40mg, Esomeprazole 20mg / 40mg
Antidiarrhoeals Loperamide HCl 2mg
Antispasmodics Dicyclomine HCl 10mg / 20mg, Mebeverine HCl 135mg
Combination GI Pantoprazole + Domperidone, Omeprazole + Domperidone, Rabeprazole + Levosulpiride SR
H2 Blockers Famotidine 20mg / 40mg, Ranitidine 150mg
Antiflatulents / Antacids Simethicone combinations, Aluminium Hydroxide combinations
Prokinetics Domperidone 10mg, Itopride HCl 50mg

Enquire Now

    WHY 9M INDIA FOR GASTROINTESTINAL DRUGS

    Why pharmaceutical buyers choose 9M India for gastrointestinal drugs capsules

    • Enteric-coated pellet capsule technology

      PPI molecules including Omeprazole, Lansoprazole and Pantoprazole are acid-labile and require enteric-coated pellet capsule formulation to protect the active ingredient from gastric acid degradation. 9M India manufactures enteric-coated pellet capsules with full dissolution validation data, coating uniformity records and multi-point pH-change dissolution profiles.

    • Full PPI range from one manufacturer

      9M India manufactures all four major PPIs — Omeprazole, Lansoprazole, Pantoprazole and Esomeprazole — plus combination PPI + Domperidone and PPI + Levosulpiride formulations. Export buyers can source their complete PPI portfolio from a single WHO-GMP certified supplier.

    • Combination GI formulations for differentiated markets

      Fixed-dose combination GI capsules — such as Pantoprazole + Domperidone and Rabeprazole + Levosulpiride SR — command better market positioning and compliance in markets where patients prefer combination therapy. 9M India manufactures these alongside standalone molecules for a complete GI portfolio.

    Molecule Grid

    Key gastrointestinal drugs capsule formulations at 9M India

    • 01

      Omeprazole 20mg | Gastrointestinal | Enteric-coated pellet capsule | PPI

    • 02

      Omeprazole 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI

    • 03

      Lansoprazole 15mg / 30mg | Gastrointestinal | Enteric-coated pellet capsule | PPI

    • 04

      Pantoprazole 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI

    • 05

      Esomeprazole 20mg / 40mg | Gastrointestinal | Enteric-coated pellet capsule | PPI

    • 06

      Loperamide HCl 2mg | Gastrointestinal | Hard gelatin capsule | Antidiarrhoeal

    • 07

      Dicyclomine HCl 10mg / 20mg | Gastrointestinal | Hard gelatin capsule | Antispasmodic

    • 08

      Domperidone 10mg | Gastrointestinal | Hard gelatin capsule | Prokinetic

    • 09

      Famotidine 20mg / 40mg | Gastrointestinal | Hard gelatin capsule | H2 Blocker

    • 10

      Pantoprazole + Domperidone | Gastrointestinal combination | Capsule | PPI + Prokinetic

    Export markets & regulatory

    Export markets & regulatory readiness

    9M India exports gastrointestinal capsules to 15+ countries across Phase 1 markets including the UAE, Iraq, Egypt, Mexico, Russia, Kazakhstan and others in the Middle East, CIS, Africa and ASEAN. PPIs, antidiarrhoeals and antispasmodics are consistently among the top-volume essential medicines in these markets.

    • WHO-GMP Certificate

    • DCGI Manufacturing Licence

    • Certificate of Pharmaceutical Product (CoPP)

    • Certificate of Analysis (CoA) — batch-wise

    • CTD / ACTD Dossier — on request

    • Stability Data — ICH Zone IVb (30°C/75% RH)

    Partner with 9M India for gastrointestinal drugs capsule supply

    Whether you are sourcing PPIs, antidiarrhoeals, antispasmodics or combination GI capsules — for institutional supply, government tenders or export distribution — 9M India delivers WHO-GMP certified manufacturing with complete documentation and enteric-coated pellet capsule expertise.

    • WHO-GMP
      Certified

    • 1,000+
      Formulations

    • 15+ Countries
      Supplied

    • DCGI
      Approved

    We keep answer short

    Frequently asked questions — gastrointestinal drugs capsules

    • 01

      Yes. 9M India manufactures Omeprazole, Lansoprazole, Pantoprazole and Esomeprazole as enteric-coated pellet hard gelatin capsules at its WHO-GMP certified facility. The enteric-coated pellet design is essential for PPI molecules to protect them from gastric acid and ensure full bioavailability in the small intestine.

    • 02

      9M India manufactures all four major PPIs: Omeprazole (20mg / 40mg), Lansoprazole (15mg / 30mg), Pantoprazole (40mg) and Esomeprazole (20mg / 40mg). Combination PPI formulations including Pantoprazole + Domperidone and Rabeprazole + Levosulpiride SR are also available.

    • 03

      Yes. 9M India manufactures Loperamide Hydrochloride 2mg hard gelatin capsules — a WHO Essential Medicine for the symptomatic treatment of acute and chronic diarrhoea. Loperamide is in consistent demand across all our export markets, particularly in Africa and ASEAN.

    • 04

      Yes. 9M India manufactures fixed-dose combination GI capsules including Pantoprazole + Domperidone and Omeprazole + Domperidone. These combination formulations address both acid suppression and gastric motility in one capsule and are widely used across South Asian and Middle Eastern markets.

    • 05

      Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, CoPP, batch CoA, ICH Zone IVb stability data (including dissolution profiles for enteric-coated formulations) and CTD/ACTD dossiers on request for all gastrointestinal capsule formulations.

    Looking for something specific?

    At 9M India Limited, trust through quality, transparency, performance.